Bio

Laurie Burlingame has a diverse practice representing clients on a broad spectrum of transactions in the life sciences and technology industries, including initial and follow-on public offerings, venture capital financings, de-SPAC transactions, and mergers and acquisitions (M&A). She regularly serves as outside general counsel to clients, advising management teams and boards of directors on a variety of matters throughout the lifecycles of various companies, including formation and founder issues, licensing transactions, strategic collaborations, commercial transactions, corporate governance, disclosure requirements, and other general corporate matters. Laurie’s clients include pharmaceutical, medical device, diagnostics, biological materials and tools, and technology companies. She also represents life sciences–focused venture capital firms in connection with their portfolio company investments. Laurie is active in several nonprofit organizations, serving on the boards of directors for the Massachusetts chapter of the Association for Women in Science, Sitters Without Scholars, and Families for Depression Awareness. In addition, she is a mentor and speaker for various university and incubator programs and maintains membership in local technology and medical associations.